HIV
Tailored gene therapy approach could replace drug treatments for HIV patients
One of the biggest problems in treating HIV patients is the amount of daily individual medications it takes to keep the virus at bay. In a new study, scientists at the Stanford University School of Medicine have engineered a new approach to tailored gene therapy that they say makes key cells of the immune system resistant to attack from the HIV virus, which may eventually lead to the removal of life-long dependencies on drugs for patients living with HIV. Read More
Scientists at The Rockefeller University have found that harnessing proteins from the human immune system can suppress the HIV virus in mice. Potentially, this could lead to a therapeutic approach to treating the virus that does not require a daily application of drugs. Read More
